Respite 20 Rabeprazole Sodium Deucravacitinib
MinorIn clinical trials, taking Deucrava (Deucravacitinib) together with rabeprazole, a proton pump inhibitor, made no clinically significant difference to how the body handles Deucrava. The same was found for the other medicines tested alongside it: cyclosporine (a dual Pgp/BCRP inhibitor), fluvoxamine (a CYP1A2 inhibitor), ritonavir (a CYP1A2 inducer), diflunisal (a UGT 1A9 inhibitor), pyrimethamine (an OCT1 inhibitor) and famotidine (an H2 receptor antagonist).
Little or no effect is expected. You usually do not need to change anything, but still tell your doctor or pharmacist about every medicine you take.